C7a: A New Chemotherapy Drug for Melanoma
Author Information
Author(s): Serrano Fabiana A, Matsuo Alisson L, Monteforte Priscila T, Bechara Alexandre, Smaili Soraya S, Santana Débora P, Rodrigues Tiago, Pereira Felipe V, Silva Luis S, Machado Joel Jr, Santos Edson L, Pesquero João B, Martins Rafael M, Travassos Luiz R, Caires Antonio CF, Rodrigues Elaine G
Primary Institution: Universidade Federal de São Paulo, São Paulo, Brazil
Hypothesis
Does the cyclopalladated complex C7a induce apoptosis in melanoma cells?
Conclusion
C7a is an effective chemotherapeutic agent against both primary and metastatic tumors, including those resistant to cisplatin.
Supporting Evidence
- C7a interacts with mitochondrial thiol groups, leading to apoptosis.
- C7a was effective against murine melanoma and human tumor cells.
- C7a induced significant cytotoxic effects in cisplatin-resistant cell lines.
- C7a treatment resulted in increased cytosolic calcium and decreased ATP levels.
- C7a activated caspases, indicating the induction of apoptosis.
- C7a significantly reduced lung metastatic nodules in a preclinical model.
Takeaway
C7a is a new drug that helps kill cancer cells by making them die in a specific way, which is good for treating melanoma.
Methodology
The study involved treating melanoma cells with C7a and evaluating apoptosis-related parameters, both in vitro and in a preclinical model.
Participant Demographics
Murine and human tumor cell lines, including cisplatin-resistant ones.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website